US equities
|
SPCX
$162.25
▲+9.78%
MU
$908.04
▲+1.34%
TSLA
$385.64
▲+3.19%
NVDA
$218.54
▲+0.96%
SNDK
$1,363.80
▼-0.12%
GOOGL
$331.41
▼-2.60%
META
$704.71
▲+1.51%
AMD
$544.07
▲+1.74%
SPCX
$162.25
▲+9.78%
MU
$908.04
▲+1.34%
TSLA
$385.64
▲+3.19%
NVDA
$218.54
▲+0.96%
SNDK
$1,363.80
▼-0.12%
GOOGL
$331.41
▼-2.60%
META
$704.71
▲+1.51%
AMD
$544.07
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Ablexis, LLC
Ablexis Announce License Agreement with Novo
October 14, 2026
From
Ablexis, LLC
Via
ACCESS Newswire
Ablexis Announces License Agreement with Adimab
February 09, 2023
From
Ablexis, LLC
Via
Business Wire
Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.
May 04, 2021
From
Ablexis, LLC
Via
Business Wire